Guangxi Xinhai Pharmaceutical Technology

Guangxi Xinhai Pharmaceutical Technology is a pharmaceutical company based in Nanning, China, and serves as the primary chemical drug research and development subsidiary of the Guangxi Wuzhou Zhongheng Group. The company specializes in the development, manufacturing, and commercialization of small molecule therapeutics, with a strong focus on cardiovascular diseases, oncology, and metabolic disorders. Its integrated operations include a dedicated R&D center for chemical drugs, as well as GMP-certified facilities for the production of both active pharmaceutical ingredients (APIs) and finished dosage forms. Xinhai Pharmaceutical is recognized as a national high-tech enterprise and plays a pivotal role in its parent company's strategic expansion into modern chemical medicine. The company's portfolio includes a range of generic products and several innovative drug candidates currently in various stages of development. By leveraging its technical expertise and manufacturing scale, Xinhai Pharmaceutical aims to provide high-quality, affordable healthcare solutions to the Chinese market.